Neoadjuvant chemotherapy (FLEP regimen)for gastric cancer with advanced lymph nodes metastasis

Guo-li LI,Yang BAO,Ning LI,Jie-shou LI
DOI: https://doi.org/10.3969/j.issn.1007-9610.2005.05.010
2005-01-01
Abstract:Objective To elucidate the efficacy of FLEP regimen, used as neoadjuvant chemotherapy for unre- sectable gastric cancer with advanced abdominal lymph node metastasis. Methods !FLEP regimen: 5-FU 370mg/m2, iv, day1-5; Leukovorin 30mg, day1-5; CDDP 70mg/m2and Epotoside 70mg/m2, ia, day 6 and 20, The regimen was adminis- tered to 14 patients with unresectable gastric cancer with advanced lymph node metastasis. Computer tomography (CT) re- vealed advanced metastasis in LN Stations No.8,9,12,13,14 and 16 with main blood vessel(s) or adjacent structure(s) in- volved in 9 of the 14 patients; the other 5 patients suffered from recurrent lymph nodes metastases after previous abdomi- nal exploration. Results !The general conditions and symptoms of the patients improved evidently after the treatment. On CT examination, of the 9 patientes, only one showed NC (no change) and remained nonresectable, 8 of them (88.9%) showed PR (partial remission) and were performed total gastrectomy, subtotal gastrectomy or combined gastrectomy, with D2+αor D3+No.16 lymphadenectomy successfully; the operated patients all survived up to present, the longest record be- ing 26 months. In the other 5 patients, only one showed no response; no operations were performed in all these patients. Two patients died in the 8th and the 15th month after chemotherapy; the other 3 remained alive till now, with the longest survival record being 15 months. Conclusions The FLEP regimen produces an evident effect on gastric cancer patients with advanced lymph node metastasis and could downstage a number of these patients and give them another chance for surgery.
What problem does this paper attempt to address?